实用肝脏病杂志 ›› 2011, Vol. 14 ›› Issue (1): 29-30.doi: 10.3969/j.issn.1672-5069.2011.01.010

• 论著 • 上一篇    下一篇

MELD评分评估血浆置换治疗慢性乙型重型肝炎的疗效

刘雯   

  1. 236015 安徽省阜阳市第二人民医院肝病一科
  • 收稿日期:2010-09-06 出版日期:2011-02-10 发布日期:2016-04-15
  • 作者简介:刘雯 男,36岁,主治医师。E-mail:lwhappyhappy1974@sohu.com

Model for end-stage liver disease to predict survival in patients with chronic severe hepatitis B

LIU Wen   

  1. Department of Liver Disease,Second Municipal People’s Hospital,Fuyang 236015,Anhui Province,China
  • Received:2010-09-06 Online:2011-02-10 Published:2016-04-15

摘要: 目的 应用终末期肝病模型(MELD)评价血浆置换(PE)治疗慢性乙型重型肝炎的临床疗效。方法 对112例慢性乙型重型肝炎患者进行PE治疗,检测总胆红素、国际标准化比值和肌酐水平以计算MELD分值。按照治疗前患者MELD分值<30分、30~40分和≥40分分成三组,观察各组3个月内的病死率。结果 PE治疗后112例患者血生化指标改善;3个月内,在MELD评分<30的63例患者中,死亡12例(19%);在30≤MELD评分<40分的34例患者中,死亡20例(58.8%);在MELD评分≥40分的15例患者中,死亡15例(100%,P<0.05)。结论 MELD评分系统能预测PE治疗慢性乙型重型肝炎患者的预后。

关键词: 慢性乙型肝炎, 重型肝炎, 血浆置换, 终末期肝病模型

Abstract: Objective To evaluate the value of model for end-stage liver disease(MELD)scoring system in predicting the prognosis of patients with chronic severe hepatitis B receiving plasma exchange. Methods Total serum bilirubin,international normalized ratio and creatinine were determined pre-treatment and post-treatment in 112 patients with chronic severe hepatitis B who were treated with plasma exchange. The patients were divided into three groups according to MELD score. The mortality rate within three months post-treatment were compared in three groups. Results In 63 cases with MELD score less then 30,19% patients died;in 34 cases with MELD score between 30 and 40,58.8% died;and in 15 cases with MELD score more than 40,none of them survived. The mortality rates among the three groups were significantly different(P<0.05). Conclusion MELD scoring system is useful in predicting the prognosis of patients with chronic severe hepatitis B treated with plasma exchange.

Key words: Chronic hepatitis B, Severe hepatitis, Plasma exchange, Model for end-stage liver disease scoring system